XBIO: Xenetic Biosciences, Inc. Stock

by  •  • Comments Off on XBIO: Xenetic Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.72
Enterprise Value ($M) -2.45
Book Value ($M) 6.01
Book Value / Share 3.90
Price / Book 0.62
NCAV ($M) 5.69
NCAV / Share 3.69
Price / NCAV 0.65

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 7.37
Current Ratio 7.37

Balance Sheet (mrq) ($M)
Current Assets 6.59
Assets 6.90
Liabilities 0.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.50
Operating Income -4.20
Net Income -3.96
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.82
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2024-03-18 13D/A CLS Therapeutics, LLC 14.00 8.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 851 3,279 25.95
2025-04-16 1,040 5,803 17.92
2025-04-15 6,205 15,607 39.76
2025-04-14 9,878 23,999 41.16

(click for more detail)

Similar Companies
VYNE – VYNE Therapeutics Inc. WHWK – Whitehawk Therapeutics, Inc.
WINT – Windtree Therapeutics, Inc. XCUR – Exicure, Inc.
XFOR – X4 Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io